Skip to content

Utility of synthesis repertory in the cases of migraine.

To study the Utility of synthesis repertory in the cases of migraine. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057981
Enrollment
40
Registered
2023-09-25
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G43- Migraine

Interventions

Intervention1: Individualised Homoeopathic Medicine: Individualised Homoeopathic Medicine On The Basis Of Symptom Similarities With Migraine By Using Synthesis Repertory Control Intervention1: Nil: Ni

Sponsors

Dr Vedant Maheshbhai Pandya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Only Those Cases Will Be Selected Which Has a Pure Diagnostic Criterion of Migraine Without Aura and Chronic Migraine. 2. Patient With Regular Follow Ups.

Exclusion criteria

Exclusion criteria: 1. Cases With Advanced and Irreversible Pathological Conditions. 2. Cases Of Migraine With Aura. 3. Cases Which Require Intensive Care Unit. 4. Cases Of Lactating and Pregnant Lady. 5. Patient With Irregular Follow Ups.

Design outcomes

Primary

MeasureTime frame
1. Sensation of Well-Being Physically and Mentally with Disappearance of All the Symptoms of Migraine- For Which Patient Approached, Without Recurrence Within Period of Study. 2. Decrease in Intensity And/or Frequency of Presenting Complaints with Feeling of Well-Being. Timepoint: 15 days

Secondary

MeasureTime frame
1. Reduction in the symptoms of migraine is evaluated through Migraine Pain Management Scale. 2. To assess the Utility of Synthesis Repertory in The Cases of Migraine.Timepoint: 3 months

Countries

India

Contacts

Public ContactDr Jignesh Patel

Jawaharlal Nehru Homoeopathic Medical College Hospital

jhpatel2003@gmail.com9909949221

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026